Logo image
Back
Intracranial dural arteriovenous fistulas with perimedullary venous drainage: analysis of the multinational CONDOR registry
Journal article   Peer reviewed

Intracranial dural arteriovenous fistulas with perimedullary venous drainage: analysis of the multinational CONDOR registry

Adriaan R E Potgieser, Hana Hallak, Michelle Connor, Jane Yuan, Diogo P Moniz Garcia, Giuseppe Lanzino, Louis J Kim, Michael R Levitt, Minako Hayakawa, Edgar A Samaniego, …
Journal of neurosurgery
08/07/2026
DOI: 10.3171/2026.2.JNS252734
PMID: 42566799

View Online

Abstract

Cognard type V dural arteriovenous fistulas (dAVFs), defined by spinal perimedullary venous drainage, represent a rare and aggressive neurovascular pathology. Comprehensive multicenter data remain scarce. The authors present the largest multicenter analysis to date, characterizing presentation, radiology, treatment, complications, and functional outcomes of Cognard type V dAVFs. The authors retrospectively analyzed patients with angiographically confirmed Cognard type V dAVFs from the Consortium for Dural Arteriovenous Fistula Outcomes Research (CONDOR), spanning 16 academic centers. Patient demographics, imaging features, treatment strategies, procedural complications, and modified Rankin Scale (mRS) scores were recorded. Among 1077 patients with dAVFs, 37 (3%) had Cognard type V lesions. The mean patient age was 57 years, and 59.5% of patients were male. Most presented with nonhemorrhagic neurological deficits (68%), while 14% had hemorrhage. The most common location was the foramen magnum (32%). Embolization was the primary treatment in 67% of cases, complete obliteration was achieved in 71% of cases. Upfront microsurgery was performed in 22% of patients (obliteration rate 88%), and radiosurgery in 14% (success rate 40%). Salvage treatment further improved obliteration outcomes. Temporary complications occurred in 8% of patients (3/37): 2 with transient neurological deficits postembolization and 1 with transient hydrocephalus after surgery. Permanent complications were observed in 3% (1/37) due to treatment-related hemorrhage. At the last follow-up (mean 2.4 years), 69% (24/35) of patients maintained or improved to an mRS score ≤ 2. No deaths occurred. Functional improvement was seen in 29% (10/35), while mRS decline was in 40% of patients (14/35), all unrelated to the dAVF itself. Cognard type V dAVFs carry a high risk of neurological morbidity. However, favorable functional outcomes are achievable with timely, multimodal intervention. Complication rates remain low, with most being transient. These data support aggressive but tailored management to prevent permanent disability in this high-risk population.
 Cognard type V dural arteriovenous fistula endovascular neurosurgery perimedullary drainage skull base vascular disorders myelopathy

Details

Metrics

2 Record Views
Logo image